Postgraduate Course: Oncology 2 (UCHM12009)

Course Outline
School	Edinburgh Medical School	College	College of Medicine and Veterinary Medicine
Credit level (Normal year taken)	SCQF Level 12 (Postgraduate)
Course type	Online Distance Learning	Availability	Not available to visiting students
SCQF Credits	10	ECTS Credits	5
Summary	The assessment and treatment of patients with urological malignancy.
Course description	Deduce the diagnosis, investigation, and management of organ-specific urological malignancies, including kidney, ureter, prostate, bladder, renal, testicular and penile cancer; Apply a constant and integrated approach to critical analysis, evaluation and synthesis of new and complex ideas, information and issues; Understand the leadership contribution and responsibilities of the urologist in the multidisciplinary management of complex surgical disease in the oncology environment.

Entry Requirements (not applicable to Visiting Students)
Pre-requisites	Students MUST have passed:	Co-requisites
Prohibited Combinations		Other requirements	None

Course Delivery Information

Academic year 2025/26, Not available to visiting students (SS1)		Quota: None
Course Start	Full Year
Timetable	Timetable
Learning and Teaching activities (Further Info)	Total Hours: 100 ( Programme Level Learning and Teaching Hours 2, Directed Learning and Independent Learning Hours 98 )
Assessment (Further Info)	Written Exam 60 %, Coursework 40 %, Practical Exam 0 %
Additional Information (Assessment)	Written Exam 60%, Coursework 40%
Feedback	Not entered
No Exam Information

Learning Outcomes
Deduce the diagnosis, investigation, and management of organ-specific urological malignancies, including kidney, ureter, prostate, bladder, renal, testicular and penile cancer; Apply a constant and integrated approach to critical analysis, evaluation and synthesis of new and complex ideas, information and issues; Understand the leadership contribution and responsibilities of the urologist in the multidisciplinary management of complex surgical disease in the oncology environment.